Close contact precautions could prevent an outbreak of crimean-congo hemorrhagic fever: A case series report from southern part of tehran

International Journal of Preventive Medicine

Volumn 4, Issue 6, 2013, Pages 715-719

  Mardani, Masoud ^a   Namazee, Najmeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crimean congo hemorrhagic fever; Outbreak; Ribavirin prophylaxis; Tick borne disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; RIBAVIRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CRIMEAN CONGO HEMORRHAGIC FEVER; FEMALE; FLUID RESUSCITATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTERNATIONAL NORMALIZED RATIO; IRAN; LEUKOCYTOSIS; LEUKOPENIA; MALE; NAIRO VIRUS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SYMPTOMATOLOGY; THROMBOCYTOPENIA; VIRUS TRANSMISSION;

EID: 84879706012     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mardani M, keshtkar-Jahromi M, Ataei B, Adibi P. A Report of Nosocomial Crimean-Congo Hemorrhagic Fever (CCHF) in Iran. Am J Trop Med Hyg 2009;81:675-678.
2. Pirkani SG, Jogezai EK, Ilyas M. Crimean-Congo hemorragic fever (CCHF) in blochistan. Survey Report. Prof Med J 2006;13:464-467.
3. Lacy MD, Smego RA. Viral hemorrhagic fevers. Adv pediatr Infect Dis 1996;12:21-53.
4. Hoogstraal H. The epidemiology of tick-borne Crimean- Congo hemorrhagic fever in Asia, Europe and Africa. J Med Entomol 1979;15:307-317.
5. Appannanvar SB, Mishra B. An update on crimean-congo hemorrhagic fever. J Glob Infect Dis 2011;3:285-292.
6. Rhanavardi M, Rajaeinejad M, Pourmalek F, Mardani M, Holakouie-Naieni K, Dowlatshahi S. Knowledge, and attitude toward Crimean-Congo hemorrhagic fever in occupationally at risk Iranian healthcare workers. J Hosp Infect 2008,69:77-85.
7. Athar MN, Baqai HZ, Ahmad M, Khalid MA, Bashir N, Ahmad AM, et al. Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan. Am J Trop Med Hyg 2003;69:284-287.
8. Ergonul O, celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with crimean Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004;39:284-287.
9. Ertugrul B, Uyar Y, Yavas K, Turan C, Oncu S, Saylak O, et al. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Intern J Infect Dis 2009;13:e431-436.
10. Athar M, Khalid MA, Ahmad AM, Bashir N, Baqai HZ, Ahmad M, et al. Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002; Contact tracing and risk assessment. Am J Trop Med Hyg 2005;72:471-473.
11. Mardani M. Nosocomial Crimean-Congo hemorrhagic fever in Iran, 1999 - 2000. Clin Microbiol Infec 2001;7(suppl 1):213.
12. Weber DJ, Rutala, WA. Risk and Prevention of nosocomial transmission of rare zoonotic iseases. Clinic Infect Dis 2001;32:446-456.
13. Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The role of ribavirin in the therapy of rimean-Congo hemorrhagic fever: Early use is promising. Eur J clin Microbiol Infect Dis 2009;28:929-933.
14. Soares-Weiser K, Thomas S, Thomson G, Garner P. Ribavirin for crimean-Congo hemorrhagic Fever: Systematic review and meta-analysis. BMC Infect Dis 2010;10:207.
15. Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari S, et al. Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and Therapies. Antiviral Res 011;90:85-92.
16. Mardani M, Keshtkar-Jahromi M, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean Congo hemorrhagic fever in Iran. Clin Infect Dis 2003;36:1613-1618.
17. Metanat M, Sharifi-Mood B, Salehi M, Alavi Naini R. Clinical outcome in Crimean-Congo hemorrhagic fever: A five-years experience in treatment of patients in oral ribavirin. Int J Virol 2006;2:21-24.
18. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, Southeast of Iran: A comparative study. Arch Iran Med 2009;12:151-153.
19. Mardani M, Keshtkar-Jahromi M. Crimean-Congo Hemorrhagic Fever. Arch Iran Med 2007;10:204-214.
20. Ghadirian L, Sayarifard A. Isn't it the time for working on public health guidance in health system of Iran? Int J Prev Med 2013;4:125-127.